Dapagliflozin in young people with type 2 diabetes. | Colorado PROFILES

Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)

Menu

History

Dapagliflozin in young

Does pay-for-performan

No Significant Relatio

See All (3) pages

Contact Us
If you have any questions or feedback please contact us.

Dapagliflozin in young people with type 2 diabetes.

Tommerdahl KL, Nelson RG, Bjornstad P. Dapagliflozin in young people with type 2 diabetes. Lancet Diabetes Endocrinol. 2022 05; 10(5):303-304.

View in: PubMed

subject areas

authors with profiles

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)